Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Journal of Clinical Oncology, Vol 23, No 24 (August 20), 2005: pp. 5651-5659
© 2005 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2005.14.712

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Renkonen, E. T.
Right arrow Articles by Peltomäki, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Renkonen, E. T.
Right arrow Articles by Peltomäki, P.

Adenomatous Polyposis Families That Screen APC Mutation–Negative by Conventional Methods Are Genetically Heterogeneous

Elise T. Renkonen, Pekka Nieminen, Wael M. Abdel-Rahman, Anu-Liisa Moisio, Irma Järvelä, Sirpa Arte, Heikki J. Järvinen, Päivi Peltomäki

From the Department of Medical Genetics, Institute of Dentistry, and Institute of Biotechnology, University of Helsinki; Laboratory of Molecular Genetics, Department of Oral and Maxillofacial Diseases, and Department of Surgery, Helsinki University Central Hospital, Helsinki, Finland

Address reprint requests to Päivi Peltomäki, Department of Medical Genetics, Biomedicum Helsinki, PO Box 63 (Haartmaninkatu 8), FIN-00014 University of Helsinki, Helsinki, Finland; e-mail: paivi.peltomaki{at}helsinki.fi

PURPOSE: One third of families with classical adenomatous polyposis (FAP), and a majority of those with attenuated FAP (AFAP), remain APC mutation–negative by conventional methods. Our purpose was to clarify the genetic basis of polyposis and genotype-phenotype correlations in such families.

PATIENTS AND METHODS: We studied a cohort of 29 adenomatous polyposis families that had screened APC mutation–negative by the protein truncation test, heteroduplex analysis, and exon-specific sequencing. The APC gene was investigated for large genomic rearrangements by multiplex ligation-dependent probe amplification (MLPA), and for allelic mRNA expression by single nucleotide primer extension (SNuPE). The AXIN2 gene was screened for mutations by sequencing.

RESULTS: Four families (14%) showed a constitutional deletion of the entire APC gene (three families) or a single exon (one family). Seven families (24%) revealed reduced or extinct mRNA expression from one APC allele in blood, accompanied by loss of heterozygosity in the APC region in six (75%) of eight tumors. In 15 families (52%), possible APC involvement could be neither confirmed nor excluded. Finally, as detailed elsewhere, three families (10%) had germline mutations in genes other than APC, AXIN2 in one family, and MYH in two families.

CONCLUSION: "APC mutation–negative" FAP is genetically heterogeneous, and a combination of MLPA and SNuPE is able to link a considerable proportion (38%) to APC. Significant differences were observed in clinical manifestations between subgroups, emphasizing the importance of accurate genetic and clinical characterization for the proper management of such families.

Supported by grants from the Sigrid Juselius Foundation, the Academy of Finland, the Finnish Cancer Foundation, K. Albin Johansson Foundation, Helsinki University Hospital Research and Development Funds (EVO), and Helsinki Biomedical Graduate School.

Authors' disclosures of potential conflicts of interest are found at the end of this article.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
A.H.S. Gylling, T.T. Nieminen, W.M. Abdel-Rahman, K. Nuorva, M. Juhola, E.I. Joensuu, H.J. Jarvinen, J.-P. Mecklin, M. Aarnio, and P.T. Peltomaki
Differential cancer predisposition in Lynch syndrome: insights from molecular analysis of brain and urinary tract tumors
Carcinogenesis, July 1, 2008; 29(7): 1351 - 1359.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
E. Castellsague, S. Gonzalez, M. Nadal, O. Campos, E. Guino, M. Urioste, I. Blanco, T. Frebourg, and G. Capella
Detection of APC Gene Deletions Using Quantitative Multiplex PCR of Short Fluorescent Fragments
Clin. Chem., July 1, 2008; 54(7): 1132 - 1140.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
A Gylling, W M Abdel-Rahman, M Juhola, K Nuorva, E Hautala, H J Jarvinen, J-P Mecklin, M Aarnio, and P Peltomaki
Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? A molecular genetic study
Gut, July 1, 2007; 56(7): 926 - 933.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
C. Pagenstecher, D. Gadzicki, D. Stienen, S. Uhlhaas, E. Mangold, N. Rahner, M. Arslan-Kirchner, P. Propping, W. Friedl, and S. Aretz
A Complex Rearrangement in the APC Gene Uncovered by Multiplex Ligation-Dependent Probe Amplification
J. Mol. Diagn., February 1, 2007; 9(1): 122 - 126.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2005 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online